Barriers and Facilitators of Persistence With Adjuvant Osimertinib
NCT07542210
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Sponsor
AstraZeneca